Apr 10, 2026
•
13 min read
Amy Webb's Convergence Outlook devotes two of ten convergences to AI × bio. I read the 40+ pages so you don't have to.
Apr 9, 2026
12 min read
Plus: An AI designed enzymes for chemistry nature never invented, and a new study shows AlphaFold reversed a long-running decline in scientific novelty.
Apr 5, 2026
Plus: A massive AI model predicts aging and a paper says AI can replace biological clocks.
Apr 2, 2026
9 min read
A Johns Hopkins professor says AI in biology is starting to look like pseudoscience. Here's what covering 60+ stories in the past six weeks have taught us.
14 min read
Plus: three ex-Ginkgo leaders argue biology needs its Bauhaus moment, and the LabOS team builds a simulation universe for AI agents.
Mar 30, 2026
Plus: Meta open-sources a digital model of the brain, an AlphaFold veteran's agent designs drugs from a text prompt, and Anthropic may be building a biology mode.
Mar 25, 2026
Plus: A $787 million AI biologics company emerges, and a multi-agent AI for dementia validated across 3 million patients.
Mar 22, 2026
Plus: The field's own reality check, and experts preferred BioReason-Pro's reasoning over curated databases.
Mar 18, 2026
16 min read
Plus: NVIDIA breaks the size ceiling on protein folding, a million AI-designed proteins get tested in actual wet labs, and OpenClaw gets a science layer.
Mar 15, 2026
Plus: Nature Biotechnology maps the agentic AI boom, a YC startup's DNA sequences get slammed by a Stanford scientist, and MedOS heads to GTC.